Gabapentin Capsule
Product Images NDC 80425-0150

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 80425-0150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig 1

Line graph showing mean pain score over 8 weeks comparing Gabapentin 3600 mg/day and placebo. The x-axis represents weeks, with a 4-week dose titration period followed by a 4-week fixed dose period. The y-axis represents mean pain score ranging from 0 to 10. Gabapentin shows a decreasing trend in mean pain score over time compared to placebo, which remains relatively stable.*

FDA Label Image

Fig 2

A line chart showing mean pain scores over 7 weeks for three groups: placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The x-axis represents weeks from baseline through a 3-week dose titration and a 4-week fixed dose period. The y-axis displays mean pain scores from 0 to 10. Gabapentin groups show a greater reduction in mean pain score over time compared to placebo.*

FDA Label Image

Fig 3

A bar graph titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies.' It compares the percentage of responders between placebo (PBO) and Gabapentin (GBP) at different dosages in two studies. Study 1 shows 12% for PBO and 29% for GBP 3600 mg. Study 2 shows 14% for PBO, 32% for GBP 1800 mg, and 34% for GBP 2400 mg. Statistical significance levels are noted with **p < 0.01 and ***p < 0.001.*

FDA Label Image

Fig 4

A scatter plot comparing percentage difference versus daily dose in mg for three studies labeled as study a, study b, and study c. Daily doses are shown on the x-axis ranging approximately from 600 mg to 1800 mg, and the difference percentage is shown on the y-axis up to 22%. Each study is represented with different colored squares: black for study a, gray for study b, and white for study c, with respective data points scattered across the different daily doses.*

FDA Label Image

Formula

A mathematical formula to estimate creatinine clearance (CLCr) based on patient age, weight, serum creatinine, and a gender adjustment factor for females. This calculation helps assess kidney function.*

FDA Label Image

Gabapentin 100mg Cap Qty 60 Ndc 80425 0150

Gabapentin 100 mg oral capsules packaging label from Advanced Rx Pharmacy of Tennessee, LLC, showing a 60-capsule count. Includes NDC 80425-0150 and storage instructions, with a note on federal law restricting use to the prescribed patient. Label has a QR code and batch/expiration details.*

FDA Label Image

Gabapentin 100mg Cap Qty 90 Ndc 80425 0150

Label for Gabapentin 100 mg capsules, 90 count, by Advanced Rx Pharmacy of Tennessee, LLC. The label includes NDC 80425-0150, lot number 90GP1001222, expiration date 12/31/2022, storage instructions for room temperature, and a QR code.*

FDA Label Image

Structure

Chemical structure of gabapentin, showing a cyclohexane ring with attached amino (CH2NH2) and carboxymethyl (CH2CO2H) functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.